“Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway”. Nigerian Journal of Physiological Sciences, bd. 40, nr. 2, december 2025, s. 251-62, https://doi.org/10.54548/.